Thursday Apr 20, 2023

May 2023 - another DTB celebration (or two), OACs and NSAIDs, and siRNA-based therapeutics

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the May 2023 issue of DTB. They celebrate 60 years since DTB became independent from The Medical Letter and discuss what DTB stands for ( They review a retrospective cohort study involving people taking oral anticoagulants that compared the risk of bleeding and embolic events in new users of NSAIDs with those not prescribed NSAIDs ( They also talk about the main review article that explores the therapeutics of siRNA medicines ( They begin by discussing the UK Government’s recent Budget statement that the MHRA will introduce a new approval process for medicines that have been licensed elsewhere.

Copyright 2023 All rights reserved.

Version: 20240320